Abstract Submission Guidelines

General Information

• The deadline for abstract submission is May 20, 2016 – 5.00 PM EST (extended to June 13^th, 2016 – 5.00 PM EST)
• The official language for the abstracts is English.
• Original scientific studies unpublished in a peer-review journal at the time of the abstract submission deadline will be considered for selection as an oral or poster presentation.  
• The first/presenting author will receive a confirmation of acceptance for oral presentation, poster presentation, or a notice of rejection, by e-mail before June 10, 2016.
• All accepted abstracts will be published in the LUPUS Journal.

How to Submit an Abstract?

                                                                                 
 
 

• Click the box above to start an abstract submission; you will first require a login name and password. After you login, please follow the instructions for each step:
  • Abstract Information
    • Abstract categories are listed below
    • Please indicate if you are applying for an Abstract Recognition Award (further information below)
  • Institution(s)
  • Author(s)
  • Presenting Author
  • Abstract Title (maximum 200 characters)
  • Abstract Content (maximum 3,000 characters)
    • Please include the following content sections:
      • Background/Purpose
      • Methods
      • Results
      • Conclusions
  • Keywords (maximum 45 characters)
    • Please separate keywords with “-”
  • Figure and Table
    • Maximum 1 image and 1 figure can be submitted.
    • Image or table is not included in the character count. 
  • Acknowledgment (maximum 300 characters)
  • Abstract Preview & Submit
    • After you complete each section, please preview your abstract, which is automatically saved. You can then login in as often as you wish before the deadline to edit your abstract. When you are ready to submit, please click on “submit to committee”; after then you will not be able to edit your abstract. After submitting your abstract successfully, you will receive a confirmation of the submission by e-mail.

 
Abstract Categories

• Biology/Biochemistry of aPL and Related Natural Proteins
• Origins of aPL (including infection)
• Genetics of aPL/APS
• Mechanism(s) of aPL-mediated Thrombosis
• Mechanism(s) of aPL-mediated Pregnancy Morbidity
• Mechanism(s) of aPL-mediated Hematologic and Other Non-criteria manifestations
• Detection and Reporting of “Criteria” aPL Tests
• Detection and Reporting of “Non-criteria” aPL Tests
• Clinical and Prognostic Significance of “Criteria” aPL Tests
• Clinical and Prognostic Significance of “Non-criteria” aPL Tests
• Epidemiology, Clinical Manifestations, and Natural History
• Autoimmune Diseases (lupus, rheumatoid arthritis, others) and aPL/APS
• Infections and aPL/APS
• Disease Activity, Risk, and Quality of Life Measurement
• Diagnostic and Classification Criteria
• Pediatric APS
• Catastrophic APS
• Prevention &  Treatment of Obstetric APS
• Prevention & Treatment of Thrombotic APS
• Future Treatment Trends including Biologic Agents
• Patient Support Material
• Other

 
Abstract Recognition Awards
Abstract Recognition Awards will provide travel support to the presenting authors of the highest scoring abstracts in different categories. Travel grants are specially intended to support young investigators; therefore applicants should be 35 years or younger as of September 24, 2016.  Authors interested in applying for an Abstract Recognition Award should be the submitting, first, and presenting author of a submitted abstract. Please click here for more information.

Further Questions
Please contact info@apsistanbul2016.org